Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

OPNT

Opiant Pharmaceuticals (OPNT)

Opiant Pharmaceuticals Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:OPNT
DatumZeitQuelleÜberschriftSymbolFirma
30/10/201221h18Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:OPNTOpiant Pharmaceuticals Inc
30/10/201220h02Business WireOPNET Technologies Investor Alert: Briscoe Law Firm and Powers Taylor, LLP Investigate Sale to Riverbed TechnologyNASDAQ:OPNTOpiant Pharmaceuticals Inc
29/10/201223h01Business WireRobbins Umeda LLP Announces an Investigation of OPNET Technologies, Inc.NASDAQ:OPNTOpiant Pharmaceuticals Inc
29/10/201222h24Edgar (US Regulatory)Annual Report (10-K)NASDAQ:OPNTOpiant Pharmaceuticals Inc
29/10/201222h17Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:OPNTOpiant Pharmaceuticals Inc
29/10/201222h15Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:OPNTOpiant Pharmaceuticals Inc
29/10/201222h15Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:OPNTOpiant Pharmaceuticals Inc
29/10/201222h15Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:OPNTOpiant Pharmaceuticals Inc
29/10/201222h14Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:OPNTOpiant Pharmaceuticals Inc
29/10/201222h13Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:OPNTOpiant Pharmaceuticals Inc
29/10/201222h12Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:OPNTOpiant Pharmaceuticals Inc
29/10/201222h11Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:OPNTOpiant Pharmaceuticals Inc
29/10/201222h10Edgar (US Regulatory)Current report filing (8-K)NASDAQ:OPNTOpiant Pharmaceuticals Inc
29/10/201222h08Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:OPNTOpiant Pharmaceuticals Inc
29/10/201222h05Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:OPNTOpiant Pharmaceuticals Inc
29/10/201221h08Business WireSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of OPN...NASDAQ:OPNTOpiant Pharmaceuticals Inc
29/10/201214h50Dow Jones NewsRiverbed Agrees to Buy Opnet for $1 BillionNASDAQ:OPNTOpiant Pharmaceuticals Inc
29/10/201213h36GlobeNewswire Inc.OPNET Announces Financial Results for the Second Quarter of Fiscal 2013NASDAQ:OPNTOpiant Pharmaceuticals Inc
29/10/201213h30Business WireRiverbed to Acquire OPNET Technologies, Inc.NASDAQ:OPNTOpiant Pharmaceuticals Inc
04/10/201222h15GlobeNewswire Inc.OPNET Technologies, Inc. Schedules Fiscal 2013 Second Quarter Results Teleconference/Webcast for Wednesday, November 7, 2012NASDAQ:OPNTOpiant Pharmaceuticals Inc
24/09/201214h00PR Newswire (US)Lightlake Therapeutics Appoints Dr. David Kessler as Strategic AdvisorNASDAQ:OPNTOpiant Pharmaceuticals Inc
13/09/201212h03Edgar (US Regulatory)Current report filing (8-K)NASDAQ:OPNTOpiant Pharmaceuticals Inc
12/09/201200h31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPNTOpiant Pharmaceuticals Inc
12/09/201200h12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPNTOpiant Pharmaceuticals Inc
11/09/201223h53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPNTOpiant Pharmaceuticals Inc
04/09/201223h57Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPNTOpiant Pharmaceuticals Inc
22/08/201214h30GlobeNewswire Inc.IDEAS Investor Conferences Announce The Midwest IDEAS Investor Conference to be held August 28, 2012 in ChicagoNASDAQ:OPNTOpiant Pharmaceuticals Inc
20/08/201222h05GlobeNewswire Inc.OPNET Positioned in the "Leaders" Quadrant of the Magic Quadrant for Application Performance MonitoringNASDAQ:OPNTOpiant Pharmaceuticals Inc
14/08/201214h25GlobeNewswire Inc.OPNET's Annual Conference Draws Record ParticipationNASDAQ:OPNTOpiant Pharmaceuticals Inc
08/08/201214h30PR Newswire (US)Lightlake Therapeutics Inc. Announces Positive Final Phase II Clinical Trial Results of Binge Eating Disorder TreatmentNASDAQ:OPNTOpiant Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:OPNT